Arnon I. Dreyfuss - Concepedia

Author

Arnon I. Dreyfuss

Dana-Farber Cancer Institute

Also Known As

A Dreyfuss, A I Dreyfuss, A. Dreyfuss, A. I. Dreyfuss, ARNON I. DREYFUSS, Arnon I. Dreyfuss

Publications

882

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University

About

Arnon I. Dreyfuss is an author at Dana-Farber Cancer Institute specializing in cancer research, radiation oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	267
2	Pathology	4	4	267
3	Health Sciences	2	2	193
4	Pharmacology	2	2	196
5	Surgical Oncology	1	1	153

Arnon I. Dreyfuss

Publications

858

Citations

H-Index

Page 1

	Year	Citations
Docetaxel: an active drug for squamous cell carcinoma of the head and neck. Arnon I. Dreyfuss, J. Clark, Charles M. Norris, Journal of Clinical Oncology	1996	233
Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin Arnon I. Dreyfuss, John R. Clark, Barbara G. Fallon, Cancer Surgical OncologyPathologyMetronomic ChemotherapySalivary Gland CarcinomasTumor Biology	1987	153
Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck Arnon I. Dreyfuss Annals of Internal Medicine	1990	125
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial. A. Dimitrios Colevas, Paul M. Busse, Charles M. Norris, Journal of Clinical Oncology	1998	113
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results. J. Clark, Paul M. Busse, Charles M. Norris, Journal of Clinical Oncology	1997	60
Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo. James E. Wright, Arnon I. Dreyfuss, I el-Magharbel, PubMed PathologyPharmacotherapyPharmaceutical Chemistry5,10-Methylenetetrahydrofolate PoolsTumor Biology	1989	43
Nasopharyngeal Carcinoma: The Dana-Farber Cancer Institute Experience with 24 Patients Treated with Induction Chemotherapy and Radiotherapy John R. Clark, Rarbara G. Fallon, John T. Chaffey, Annals of Otology Rhinology & Laryngology Radiation TherapyDistant FailureMedicineCancer ManagementNasopharyngeal Cancer	1987	40
Analysis of Prognostic Factors in Squamous Cell Carcinomas of the Head and Neck Arnon I. Dreyfuss, John R. Clark Hematology/Oncology Clinics of North America Prognostic FactorsMedicineNasopharyngeal CancerPathologyHead And Neck Oncology	1991	31
The role of cisplatin in treatment regimens for squamous cell carcinoma of the head and neck. John R. Clark, Arnon I. Dreyfuss PubMed	1991	29
Lipid‐associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck Arnon I. Dreyfuss, John R. Clark, Janet W. Andersen Cancer	1992	19

Page 1